South San Francisco, CA, June 20, 2018 – Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in...
Scott will join a panel discussion focusing on raising US venture capital at the BioFinance 2012 conference in Toronto on May 29-30, 2012
News | 05. 14. 2012
Scott will sit on a panel focusing on raising US venture capital at the BioFinance 2012 conference in Toronto on May 29-30, 2012
